Results 291 to 300 of about 4,278,761 (348)

Phenotyping Healthcare Use 2–3 Decades Before the First Multiple Sclerosis Demyelinating Event

open access: yesAnnals of Clinical and Translational Neurology, EarlyView.
ABSTRACT Objective Phenotype hospital, physician, and emergency department (ED) visits by diagnoses and specialty up to 29 years pre‐multiple sclerosis (MS) onset versus a matched population without MS. Methods We identified people with MS (PwMS) using population‐based administrative data from Ontario, Canada (1991–2020).
Helen Tremlett   +8 more
wiley   +1 more source

miR-144-3p targeting FLRT3 in osteogenic differentiation of mandibular bone marrow mesenchymal stem cells. [PDF]

open access: yesHum Genomics
Tian J   +9 more
europepmc   +1 more source

Plasma microRNA Signature as Predictive Marker of Clinical Response to Therapy During Multiple Sclerosis

open access: yesAnnals of Clinical and Translational Neurology, EarlyView.
ABSTRACT Objective Despite the availability of effective therapies for Multiple Sclerosis (MS), the unpredictable nature of disease progression and the variability in individual treatment outcomes call for reliable biomarkers. This pilot study aims to investigate the potential of plasma circulating microRNAs (miRNAs) as predictive biomarkers for ...
Fortunata Carbone   +19 more
wiley   +1 more source

β-Catenin: A Key Molecule in Osteoblast Differentiation. [PDF]

open access: yesBiomolecules
Wróbel E   +3 more
europepmc   +1 more source

Small cell lung cancer differentiation in patients with driver mutant non-small cell lung cancer: a single center experience. [PDF]

open access: yesJ Cancer Res Clin Oncol
Yıldız O   +7 more
europepmc   +1 more source

Home - About - Disclaimer - Privacy